WisdomTree BioRevolution Fund Rating $23.08 -0.35 (-1.49%) As of 09/4/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.70Holdings in WDNA have an aggregate rating of Moderate Buy based on 423 analyst ratings issued in the past year covering 23 companies (55.1% of the portfolio).WDNA Aggregate Price Target$23.08High Prediction$23.08Average Prediction$23.08Low Prediction$23.08Holdings in WDNA have an aggregate price target of $23.08 and a range of $23.08 to $23.08 covering 23 companies (55.1% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 WDNA Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.06%TWSTTwist Bioscience$124.72-3.1%1.5409 of 5 stars2.70$98.30 -21.2%10Positive NewsGap Down4.05%LLYEli Lilly and Company$1,147.06-1.1%4.9447 of 5 stars2.83$1,292.18 12.7%30Trending NewsAnalyst Upgrade3.68%MRNAModerna$145.55-2.2%1.469 of 5 stars2.08$76.72 -47.3%24Trending NewsAnalyst DowngradeInsider TradeOptions VolumeAnalyst RevisionGap Up2.97%JNJJohnson & Johnson$275.12-1.2%4.5805 of 5 stars2.80$272.83 -0.8%25Trending NewsAnalyst ForecastInsider TradeAnalyst Revision2.91%IMNMImmunome$26.76-1.5%2.6196 of 5 stars2.85$34.64 29.4%13Positive News2.66%TXG10x Genomics$62.65-0.9%1.3882 of 5 stars2.24$40.57 -35.2%17Analyst Forecast2.64%NTRANatera$328.18+0.2%2.4888 of 5 stars2.82$319.38 -2.7%22Positive NewsInsider Trade2.27%UTHRUnited Therapeutics$487.61-0.5%4.7215 of 5 stars2.85$646.00 32.5%13Trending NewsInsider Trade2.19%DARDarling Ingredients$65.32-0.7%3.499 of 5 stars2.92$69.00 5.6%13Positive News2.10%TEMTempus AI$64.62-0.1%2.4727 of 5 stars2.50$68.93 6.7%18Analyst UpgradeInsider Trade2.07%GPCRStructure Therapeutics$47.342.1311 of 5 stars2.89$110.91 134.3%18Positive News2.06%STOKStoke Therapeutics$29.81-0.6%3.0663 of 5 stars2.82$44.25 48.4%11News CoverageInsider Trade1.81%RVMDRevolution Medicines$210.02-0.4%2.4621 of 5 stars2.95$200.74 -4.4%22Positive NewsInsider Trade1.78%TMOThermo Fisher Scientific$612.75-0.9%4.2252 of 5 stars2.88$619.41 1.1%24Positive NewsAnalyst Upgrade1.74%AMGNAmgen$437.23-1.6%4.0226 of 5 stars2.40$381.68 -12.7%30Trending NewsAnalyst ForecastAnalyst Revision1.73%CTVACorteva$87.78-0.9%3.6503 of 5 stars2.61$91.50 4.2%23Positive NewsEx-Dividend1.72%ROIVRoivant Sciences$34.93+1.5%1.9548 of 5 stars2.85$35.14 0.6%13Insider Trade1.71%CRSPCRISPR Therapeutics$55.79-1.2%2.5174 of 5 stars2.61$68.06 22.0%181.70%KRYSKrystal Biotech$358.24-3.6%3.0707 of 5 stars2.92$365.40 2.0%13News CoveragePositive NewsInsider Trade1.59%BEAMBeam Therapeutics$29.66+0.7%2.2379 of 5 stars2.69$49.00 65.2%13News CoverageAnalyst Upgrade1.59%GILDGilead Sciences$150.99-0.2%3.7092 of 5 stars2.86$158.04 4.7%29Trending NewsAnalyst DowngradeInsider TradeAnalyst Revision1.54%ARWRArrowhead Pharmaceuticals$86.34-0.2%2.0924 of 5 stars2.62$98.42 14.0%13Analyst Forecast1.54%BGBunge Global$118.97-1.0%4.2162 of 5 stars2.91$132.67 11.5%11Positive News This page (BATS:WDNA) was last updated on 9/6/2026 by MarketBeat.com Staff. From Our PartnersThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThis looks like plywood. It's not.AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHow to Think About a $500K Roth Conversion and the 35% BracketFor 2026, the 35 percent federal tax bracket starts at 512,450 dollars in taxable income for joint filers and ...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WDNA Stock Alerts